Brain natriuretic peptide and other cardiac markers predicting left ventricular remodeling and function two years

Regina Grybauskiene1, Dovile Karciauskaite, Julija Brazdzionyte

  • 1Institute of Cardiology, Kaunas University of Medicine, Sukileliu 17, 50161 Kaunas, Lithuania. reggryb@med.kmu.lt

Insights

Brain natriuretic peptide levels in the acute phase of myocardial infarction correlate with cardiac injury markers and left ventricular remodeling. These markers may help predict future heart function after heart attack.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Left ventricular remodeling is a critical process following myocardial infarction, often leading to heart failure.
  • Understanding the early markers of this remodeling is crucial for patient outcomes.

Purpose of the Study:

  • To assess biochemical markers of cardiac remodeling post-myocardial infarction.
  • To compare these markers with clinical indicators of left ventricular remodeling.

Main Methods:

  • Measured brain natriuretic peptide, troponin I, CK, CK-MB, and LDH in 30 acute myocardial infarction patients.
  • Assessed brain natriuretic peptide and echocardiographic parameters over 2 years post-MI.

Main Results:

  • Brain natriuretic peptide levels correlated with left ventricular geometry and remodeling severity in the acute phase.
  • Elevated brain natriuretic peptide, LDH, and troponin I in the acute phase predicted increased left ventricular diameter over 2 years.

Conclusions:

  • Acute phase brain natriuretic peptide levels are linked to myocardial injury and left ventricular remodeling.
  • Brain natriuretic peptide and troponin I may predict subsequent cardiac function after myocardial infarction.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...